Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sanofi (SNY) Equity Ratio (2016 - 2025)

Sanofi's Equity Ratio history spans 12 years, with the latest figure at 0.56 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 3.56% to 0.56 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.56, a 3.56% decrease, with the full-year FY2025 number at 0.56, down 3.56% from a year prior.
  • Equity Ratio hit 0.56 in Q4 2025 for Sanofi, down from 0.58 in the prior quarter.
  • Over the last five years, Equity Ratio for SNY hit a ceiling of 14.24 in Q4 2021 and a floor of 0.56 in Q4 2025.
  • Historically, Equity Ratio has averaged 5.36 across 5 years, with a median of 0.59 in 2023.
  • Biggest five-year swings in Equity Ratio: plummeted 94.6% in 2023 and later fell 0.31% in 2024.
  • Tracing SNY's Equity Ratio over 5 years: stood at 14.24 in 2021, then dropped by 23.89% to 10.84 in 2022, then plummeted by 94.6% to 0.59 in 2023, then fell by 0.31% to 0.58 in 2024, then fell by 3.56% to 0.56 in 2025.
  • Business Quant data shows Equity Ratio for SNY at 0.56 in Q4 2025, 0.58 in Q4 2024, and 0.59 in Q4 2023.